Nachrichten zur Merck & Co Aktie

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Merck eyes growth beyond Keytruda with PAH drug Winrevair, aiming to offset the looming loss of exclusivity in 2028.…

Kassenschlager Keytruda: KGV einstellig, 4 Prozent Dividende: Merck-Aktie zu günstig um wahr zu sein?

DAX auf Erholungskurs – Aroundtown, Infineon, Mercedes-Benz, Merck, Munich Re, SUSS, TUI und Zalando im Check

Neu aufkeimende Ängste vor einer Eskalation im Handelsstreit haben dem DAX am Dienstag Verluste beschert. Der deutsche Leitindex schloss daher…

DAX auf Erholungskurs – Aroundtown, Infineon, Mercedes-Benz, Merck, Munich Re, SUSS, TUI und Zalando im Check

Neu aufkeimende Ängste vor einer Eskalation im Handelsstreit haben dem DAX am Dienstag Verluste beschert. Der deutsche Leitindex schloss daher…

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Für rund drei Milliarden Euro: Merck schließt größten Pharma-Deal seit Jahrzehnten ab

Der Pharmakonzern Merck hat die rund drei Milliarden Euro schwere Übernahme der US-Biotechfirma SpringWorks unter Dach und Fach gebracht. Von…

ROUNDUP: Merck schließt größten Pharma-Deal seit Jahrzehnten ab

DARMSTADT (dpa-AFX) - Der Darmstädter Merck-Konzern hat die größte Übernahme im Pharma-Geschäft seit fast 20 Jahren abgeschlossen. Der Kauf des…

Arzneibranche: Merck schließt größten Pharma-Deal seit Jahrzehnten ab

Nach mehreren Flops in der eigenen Arzneiforschung setzt der Dax-Konzern auf eine Milliarden-Übernahme. Profitieren könnten Patienten mit seltenen Tumor-Erkrankungen.…

Merck schließt größten Pharma-Deal seit Jahrzehnten ab

Der Darmstädter Merck-Konzern hat die größte Übernahme im Pharma-Geschäft seit fast 20 Jahren abgeschlossen. Der Kauf des US-Krebsspezialisten Springworks Therapeutics…

HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?

Artificial intelligence (AI), big tech, and cryptocurrencies all have their fans among investors, and with good reason. All can add…

DGRO Is a Popular Dividend ETF for Passive Income, but Is It the Best?

Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

Merck (MRK) closed the most recent trading day at $78.83, moving 1.05% from the previous trading session.…

RFK Jr.s CDC vaccine panel backs Merck RSV shot for infants

The votes in favor of Mercks shot are a sigh of relief after Kennedy gutted the panel and tapped replacements,…

Will MRKs Growing Pipeline Help Navigate the Looming Keytruda LOE?

Mercks growing pipeline, with nearly 20 new launches ahead, is set to reshape its portfolio as Keytrudas 2028 patent expiry…

2 Stocks Too Cheap to Ignore at These Prices

The S&P 500 flirted with bear-market territory earlier this year. Although it has mostly recovered, plenty of companies are still…

MRKs Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Mercks Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.…

Why the Market Dipped But Merck (MRK) Gained Today

Merck (MRK) closed at $79.29 in the latest trading session, marking a +1.29% move from the prior day.…

2 Dividend Stocks to Buy and Never Sell

There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in…

Merck (MRK) Dips More Than Broader Market: What You Should Know

Merck (MRK) concluded the recent trading session at $78.28, signifying a -3.31% move from its prior days close.…

Slowing Gardasil Sales Hurt MRKs Top Line: Is Recovery in the Cards?

Mercks Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…

Merck bid to stop Fosamax suit thwarted by Supreme Court

…

Merck trotzt Kennedy

Der Pharmakonzern erhält die wichtige US-Zulassung für ein Vakzin. Der dortige Gesundheitsminister wird derweil seinem Ruf als Impfskeptiker gerecht Der…

2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility

Broader equities have not performed particularly well in 2025. The S&P 500 is barely in the black year to date.…

Heres Why Merck (MRK) Fell More Than Broader Market

In the most recent trading session, Merck (MRK) closed at $80.32, indicating a -1.27% shift from the previous trading day.…

Why Summit Therapeutics Stock Tanked Today

An analysts downbeat new take on Summit Therapeutics (NASDAQ: SMMT) pushed its stock downward on Hump Day. At the end…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Many blue chip stocks pay attractive dividends. The Dow Jones Industrial Average (DJINDICES: ^DJI) is loaded with blue chip stocks.…

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) closed at $81.35 in the latest trading session, marking a +2.55% move from the prior day.…

Merck: Best Case For Option Collars Well Ever See

…

Drug pricing reform talks with US government lack clarity, industry executives say

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how…

Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.…

Will Mercks Keytruda Continue to Drive Growth Amid Looming LOE?

MRK leans on Keytruda for growth as exclusivity loss nears, with new combos and launches aiming to ease reliance.…

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Mercks shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.…

US FDA approves Mercks RSV antibody for infants

The U.S. Food and Drug Administration on Monday approved Mercks preventive antibody shot to protect infants up to one year…

Apple, Warner Bros and Merck rise premarket; Tesla, Robinhood fall By Investing.com

Apple, Warner Bros and Merck rise premarket; Tesla, Robinhood fall…

Mercks cholesterol drug meets main goal in late-stage studies

Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.…

Neue potenzielle Behandlungsstrategie für Hirnmetastasen und leptomeningeale Erkrankung: HER3-DXd zeigt vielversprechende Ergebnisse in der Phase-II-TUXEDO-3-Studie bei Patienten mit begrenzten Therapieoptionen

CHICAGO--(BUSINESS WIRE)--Das führende internationale medizinische Forschungsunternehmen MEDSIR gab heute die positiven Ergebnisse der TUXEDO-3-Studie auf der Jahrestagung 2025 der American…

dpa-AFX ProFeed